Andrzej Maćkiewicz

Poznan University of Medical Sciences — Poland

Immunology and Microbiology · Life Sciences

54h-index25.3kcitations338works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(57), CAR-T cell therapy research(49), Cancer Immunotherapy and Biomarkers(47), Gut microbiota and health(33), Melanoma and MAPK Pathways(27)

Publications333 total

Custom Glial Network Architectures for the Classification of Large Text Corpora: A Case Study of Complaint Analysis in the Polish State Railways
Lecture notes in computer science·2025
Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy
International Journal of Molecular Sciences·2025Open Access
Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy
Preprints.org·2025Open Access
lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients
Biomedicines·2025· 4 citedOpen Access
Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy
Cancer Immunology Immunotherapy·2025· 1 citedOpen Access
Cellular aspects of immunity involved in the development of atherosclerosis
Frontiers in Immunology·2025· 6 citedOpen Access
Computer Network User Profiling Using Firewall Logs and ANFIS-Based Hybrid Systems
Lecture notes in computer science·2025
Perinatologia. Rzadkie sytuacje kliniczne
2025
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients
International Journal of Molecular Sciences·2024· 2 citedOpen Access
Endometriosis development in relation to hypoxia: a murine model study
Molecular Medicine·2024· 5 citedOpen Access
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
International Journal of Molecular Sciences·2024· 17 citedOpen Access
Targeting the Hippo Pathway in Cutaneous Melanoma
Cells·2024· 2 citedOpen Access
Targeting the Hippo Pathway in Melanoma
Preprints.org·2024· 2 citedOpen Access
Supplementary Figure 6 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Supplementary Figure 3 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Supplementary Table 1 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Data from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Supplementary Figure 2 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Supplementary Figure 10 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
Supplementary Figure 9 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
2024Open Access
page 1 of 17Next →

Frequent Co-authors

Piotr Rutkowski(13), Dirk Schadendorf(13), Caroline Robert(12), Vanna Chiarion‐Sileni(11), Jacob Schachter(9), Axel Hauschild(9), Michele Maio(9), Florent Grange(8), Laurent Mortier(8), Claus Garbe(7), Mario Mandalà(7), Paolo A. Ascierto(7), Bogusława Karaszewska(6), Reinhard Dummer(6), Antoni Ribas(6), Jean‐Jacques Grob(6), Daniil Stroyakovskiy(6), Célèste Lebbé(6), Georgina V. Long(5), Peter C. Heinrich(5)